Hereditary warfarin resistance;Arvelig warfarinresistens

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 27, 2000, Pages 3257-3258

  Lappegård, Knut Tore ^a  

^a Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGED; ARTICLE; CASE REPORT; DRUG RESISTANCE; GENETICS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE;

AGED; ANTICOAGULANTS; DRUG RESISTANCE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; WARFARIN;

EID: 0346485982     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147-52.
2. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effct of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
3. Nordrehaug JE, Johannessen KA, von der Lippe G. Usefulness of high-dose anticoagulants in preventing left ventricular thrombosis in acute myocardial infarction. Am J Cardiol 1985; 55: 1491-3.
4. Talstad I, Gamst ON. Warfarin resistance due to malabsorption. J Intern Med 1994; 236: 465-7.
5. Qureshi GD, Reinders TP, Swint JJ, Slate MB. Acquired warfarin resistance and weight-reducing diet. Arch Intern Med 1981; 141: 507-9.
6. Walker FB. Myocardial infarction after diet-induced warfarin resistance. Arch Intern Med 1984; 144: 2089-90.
7. Agosta FG, Liberato NL, Chiofalo F. Warfarin resistance induced by teicoplanin. Haematologica 1997; 82: 637-8.
8. Halvorsen S, Husebye T, Arnesen H. Prosthetic heart valve thrombosis during dicloxacillin therapy. Scand Cardiovasc J 1999; 33: 366-8.
9. MacLaren R, Wachsman BA, Swift DK, Kuhl DA. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature. Pharmacotherapy 1997; 17: 1331-7.
10. Brophy DF, Ford SL, Crouch MA. Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy 1998; 18: 646-9.
11. Hulse ML. Warfarin resistance: diagnosis and therapeutic alternatives. Pharmacotherapy 1996; 16: 1009-17.
12. Diab F, Feffer S. Hereditary warfarin resistance. South Med J 1994; 87: 407-9.
13. Holt RJ, Freytes CO. Familial warfarin resistance. Drug Intell Clin Pharm 1983; 17: 281-3.
14. Warrier I, Brennan CA, Lusher JM. Familial warfarin resistance in a black child. Am J Pediatr Hematol Oncol 1986; 8: 346-7.
15. Alving BM, Strickler MP, Knight RD, Barr CF, Berenberg JL, Peck CC. Hereditary warfarin resistance. Arch Intern Med 1985; 145: 499-501.
16. Hallak HO, Wedlund PJ, Modi MW, Patel IH, Lewis GL, Woodruff B et al. High clearance of (S)-warfarin in a warfarin-resistant subject. Br J Clin Pharmac 1993; 35: 327-30.
17. Keréveur A, Leclercq M, Trossaërt M, Dupeyron JP, Parent F, Horellou MH et al. Vitamin K metabolism in a patient resistant to vitamin K antagonists. Haemostasis 1997; 27: 168-73.
18. Cain D, Hutson SM, Wallin R. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver. Thromb Haemost 1998; 80: 128-33.
19. Misenheimer TM, Lund M, Baker AEM, Suttie JW. Biochemical basis of warfarin and bromadiolone resistance in the house mouse, mus musculus domesticus. Biochem Pharmacol 1994; 47: 673-8.
20. Johannessen H. Endret warfarintoleranse. Tidsskr Nor Lægeforen 1973; 93: 1236-9.